Hydroxychloroquine Trials Stopped
- All
- News
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
- Sunday July 5, 2020
- World News | ANI
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
- www.ndtv.com
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
- Saturday June 20, 2020
- World News | Agence France-Presse
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
- www.ndtv.com
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
- Thursday June 18, 2020
- World News | Agence France-Presse
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
- www.ndtv.com
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
- Tuesday May 26, 2020
- World News | Agence France-Presse
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
- www.ndtv.com
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
- Sunday July 5, 2020
- World News | ANI
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
- www.ndtv.com
-
Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment
- Saturday June 20, 2020
- World News | Agence France-Presse
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
- www.ndtv.com
-
Anti-Malarial Drug HCQ Does Not Reduce COVID-19 Mortality Rate, Says WHO, Halts Trial
- Thursday June 18, 2020
- World News | Agence France-Presse
The World Health Organization said it had decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for COVID-19 patients, finding it did not reduce the mortality rate.
- www.ndtv.com
-
WHO Stops Trial Of Anti-Malarial Drug For COVID-19 Over Safety Concerns
- Tuesday May 26, 2020
- World News | Agence France-Presse
The World Health Organization said Monday it had temporarily suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
- www.ndtv.com